Inventor · disambiguated record
Virginia L. Smith-Swintosky
Also filed as: SMITH-SWINTOSKY VIRGINIA · SMITH-SWINTOSKY VIRGINIA L
13 granted patents·19 pending applications·103 citations·filing 2001–2011
90Inventor score
Files withSMITH-SWINTOSKY VIRGINIA L22ORTHO MCNEIL PHARM INC6EISINGER MAGDALENA1ELSINGER MAGDALENA1JOHNSON & JOHNSON CONSUMER1
Top patents by PatentIndex Score
32 records- 0188US7319107B21,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsJOHNSON & JOHNSON CONSUMER·Filed 2002·Granted Jan 15, 2008·25 cites·25 claims
- 0287US7375123B21,2,4-thiadiazole derivatives as melanocortin receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2006·Granted May 20, 2008·10 cites·9 claims
- 0387US7049331B21,2,4-thiadiazole derivatives as melanocortin receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2002·Granted May 23, 2006·26 cites·19 claims
- 0487US6908902B2Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietinORTHO MCNEIL PHARM INC·Filed 2002·Granted Jun 21, 2005·26 cites·7 claims
- 0585US7786311B21,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsORTHO MCNEIL PHARM INC·Filed 2008·Granted Aug 31, 2010·6 cites·3 claims
- 0674US8716231B2Use of benzo-fused heterocycle sulfamide derivatives for the treatment of painSMITH-SWINTOSKY VIRGINIA L·Filed 2006·Granted May 6, 2014·2 cites·9 claims
- 0773US8501791B21,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsEISINGER MAGDALENA·Filed 2010·Granted Aug 6, 2013·2 cites·7 claims
- 0873US7259146B2Neuroprotective peptidesORTHO MCNEIL PHARM INC·Filed 2001·Granted Aug 21, 2007·3 cites·4 claims
- 0971US8937096B2Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorderSMITH-SWINTOSKY VIRGINIA L·Filed 2006·Granted Jan 20, 2015·1 cites·25 claims
- 1071US8492431B2Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesitySMITH-SWINTOSKY VIRGINIA L·Filed 2006·Granted Jul 23, 2013·1 cites·10 claims
- 1170US8497298B2Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levelsSMITH-SWINTOSKY VIRGINIA L·Filed 2006·Granted Jul 30, 2013·1 cites·10 claims
- 1269US8691867B2Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addictionSMITH-SWINTOSKY VIRGINIA L·Filed 2006·Granted Apr 8, 2014·0 cites·2 claims
- 1369US2009209634A1Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesisSMITH-SWINTOSKY VIRGINIA L·Filed 2009·Application pending·0 cites
- 1463US2007191474A1Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraineSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Application pending·0 cites
- 1556US2006030604A1Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulatorsELSINGER MAGDALENA·Filed 2005·Application pending·0 cites
- 1655US2007191461A1Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraineSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Application pending·0 cites
- 1755US2007191460A1Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / EpileptogenesisSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Application pending·0 cites
- 1855US2007191449A1Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of DepressionSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Application pending·0 cites
- 1954US2009170759A1Neuroprotective peptidesSMITH-SWINTOSKY VIRGINIA·Filed 2007·Application pending·0 cites
- 2051US2007155824A1Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesisSMITH-SWINTOSKY VIRGINIA L·Filed 2006·Application pending·0 cites
- 2150US2009247616A1Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxietySMITH-SWINTOSKY VIRGINIA L·Filed 2008·Application pending·0 cites
- 2249US2005261182A1Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietinORTHO MCNEIL PHARM INC·Filed 2005·Application pending·0 cites
- 2347US8853263B2Co-therapy for the treatment of epilepsy and related disordersSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Granted Oct 7, 2014·0 cites·17 claims
- 2447US2007191451A1Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agentsSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Application pending·0 cites
- 2545US2012065257A1Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraineSMITH-SWINTOSKY VIRGINIA L·Filed 2011·Application pending·0 cites
- 2645US2007293476A1Co-therapy for the treatment of epilepsy and related disordersSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Application pending·0 cites
- 2744US2007191452A1Use of benzo-heteroaryl sulfamide derivatives for the treatment of painSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Application pending·0 cites
- 2844US2007155827A1Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depressionSMITH-SWINTOSKY VIRGINIA L·Filed 2006·Application pending·0 cites
- 2944US2007191450A1Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Mania and Bipolar DisorderSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Application pending·0 cites
- 3044US2007155823A1Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agentsSMITH-SWINTOSKY VIRGINIA L·Filed 2006·Application pending·0 cites
- 3144US2007191459A1Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose LevelsSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Application pending·0 cites
- 3244US2007191453A1Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addictionSMITH-SWINTOSKY VIRGINIA L·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →